Exact Sciences Cor (NQ: EXAS )
81.08 -0.06 (-0.08%) Streaming Delayed Price Updated: 11:01 AM EDT, May 31, 2023 Add to My Watchlist
All News about Exact Sciences Cor
Cathie Wood's Funds Deliver Mixed Q3 Results: Ark Founder's Shares Take On Zoom, Roku, Teladoc And Blockchain
October 20, 2022
Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI...
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused
Exposures Financial Legal Supply Chain
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead
August 05, 2022
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following